| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.27 | 5e-07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |